HIV Combo test submitted for PMA, 6/14
June 2014—Siemens Healthcare submitted a Premarket Approval application for its Advia Centaur HIV Ag/Ab Combo assay to the Food and Drug Administration.
Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
High-speed spectrophotometer, 6/14
June 2014—QIAxpert from Qiagen is a high-speed UV/VIS spectrophotometer that enables laboratories to assess the quality and quantity of nucleic acids in up to 16 samples within just two minutes.
Semiautomated slide staining system, 6/14
June 2014—Siemens Healthcare launched the Hematek 3000 System, a semiautomated slide staining system that can stain up to 60 slides per hour.
Pressure-activated safety heel stick for infants, 6/14
June 2014—PlatinumCode added pediatric pressure-activated safety heel stick devices to its lineup. The devices come in four sizes and colors, with a range of blade depths.
ELISA kit for Alzheimer disease, 6/14
June 2014—Enzo’s quantitative, high-sensitivity ELISA kit for Alzheimer research enables identification and quantification of APP ∆C31.
Ready-to-use antibodies for cancer diagnosis, 6/14
June 2014—Dako added two new antibodies, Anti-CK 8/18 and Anti-TdT, to its portfolio. Anti-CK 8/18 is a rabbit monoclonal antibody cocktail for cytokeratin 8/18 to help classify tumors of unknown origin.
CellaVision expands product portfolio, 6/14
June 2014—CellaVision launched two new products, the CellaVision DM9600 (a replacement for CellaVision DM96), and CellaVision Advanced RBC Application, a software application for advanced analysis of red blood cells, both for use in clinical laboratories that handle large testing volumes and require a large capacity.
Randox FDA-cleared controls, 6/14
June 2014—Randox’s Acusera HbA1c received FDA clearance. It is a 100 percent human whole blood, lyophilized control with assayed values provided for high-performance liquid chromatography and a wide range of clinical chemistry analyzers. When reconstituted the control remains stable for four weeks at 2°–8°C. The control is available in levels 1 and 2, and a calibrator is also available.
In situ hybridization adapter, 6/14
June 2014—Techne added an in situ hybridization adapter to its Prime range of thermal cyclers. By inserting the adapter, a 96-well thermal cycler is converted to an in situ hybridization instrument that can accommodate up to four standard-size microscope slides with ±0.25˚C block uniformity.
SeraCare expands genetic portfolio, 6/14
June 2014—SeraCare launched its Accurun 611 product, a reference material that provides heterozygous, mutant, or wild-type scores for Factor II, Factor V, and Methlyenetetrahydrofolate reductase.